Connection
Elizabeth David to Time Factors
This is a "connection" page, showing publications Elizabeth David has written about Time Factors.
|
|
Connection Strength |
|
 |
|
 |
|
0.522 |
|
|
|
-
Stuart CM, Mott NM, Mungo AH, Meguid RA, Mitchell JD, Randhawa SK, Rove JY, David EA. Representation of women among cardiothoracic surgery editorial boards: Trends over the past 2 decades. J Thorac Cardiovasc Surg. 2025 Mar; 169(3):691-698.e6.
Score: 0.107
-
Toubat O, Ding L, Ding K, Wightman SC, Atay SM, Harano T, Kim AW, David EA. Benefit of adjuvant chemotherapy for resected pathologic N1 non-small cell lung cancer is unrecognized: A subgroup analysis of the JBR10 trial. Semin Thorac Cardiovasc Surg. 2024; 36(2):261-270.
Score: 0.095
-
Shemanski KA, Ding L, Kim AW, Blackmon SH, Wightman SC, Atay SM, Starnes VA, David EA. Gender representation among leadership at national and regional cardiothoracic surgery organizational annual meetings. J Thorac Cardiovasc Surg. 2021 Mar; 161(3):733-744.
Score: 0.083
-
David EA, Andersen SW, Beckett LA, Melnikow J, Clark JM, Brown LM, Cooke DT, Kelly K, Canter RJ. Survival benefits associated with surgery for advanced non-small cell lung cancer. J Thorac Cardiovasc Surg. 2019 04; 157(4):1620-1628.
Score: 0.072
-
Cooke DT, Gandara DR, Goodwin NC, Calhoun RF, Lara PN, Mack PC, David EA. Outcomes and efficacy of thoracic surgery biopsy for tumor molecular profiling in patients with advanced lung cancer. J Thorac Cardiovasc Surg. 2014 Jul; 148(1):36-40.
Score: 0.052
-
Stuart CM, Dyas AR, Yee EJ, Thielen O, Bronsert MR, Mungo B, McCarter MD, Randhawa SK, David EA, Michell JD, Meguid RA. Patient, facility, and surgical factors associated with significant delays to esophagectomy and subsequent poor outcomes: An analysis of 16,486 cases. J Thorac Cardiovasc Surg. 2025 May; 169(5):1385-1395.e5.
Score: 0.027
-
Stuart CM, Dyas AR, Bronsert MR, Abrams BA, Kelleher AD, Colborn KL, Randhawa SK, David EA, Mitchell JD, Meguid RA. Perioperative hypothermia in robotic-assisted thoracic surgery: Incidence, risk factors, and associations with postoperative outcomes. J Thorac Cardiovasc Surg. 2024 Jun; 167(6):1979-1989.e1.
Score: 0.025
-
Levy J, Hopkins T, Morris J, Tran ND, David E, Massari F, Farid H, Vogel A, O'Connell WG, Sunenshine P, Dixon R, Gangi A, von der H?h N, Bagla S. Radiofrequency Ablation for the Palliative Treatment of Bone Metastases: Outcomes from the Multicenter OsteoCool Tumor Ablation Post-Market Study (OPuS One Study) in 100 Patients. J Vasc Interv Radiol. 2020 Nov; 31(11):1745-1752.
Score: 0.021
-
Zhao J, Nguyen A, Ding L, David EA, Atay SM, Wightman SC, McFadden PM, Kim AW. Trends in pneumonectomy for treatment of small-cell lung cancer. Asian Cardiovasc Thorac Ann. 2020 Nov; 28(9):583-591.
Score: 0.020
-
Yao MJ, Ding L, Atay SM, Toubat O, Ebner P, David EA, McFadden PM, Kim AW. A Modern Reaffirmation of Surgery as the Optimal Treatment for Solitary Fibrous Tumors of the Pleura. Ann Thorac Surg. 2019 03; 107(3):941-946.
Score: 0.018
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|